Clinical trial of MGD 006 for the treatment of haematologic cancers
Latest Information Update: 29 Nov 2013
At a glance
- Drugs Flotetuzumab (Primary)
- Indications Haematological malignancies
- Focus Adverse reactions
- Sponsors MacroGenics
- 29 Nov 2013 New trial record